We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 13% from Oct 30 to Nov 10.
Up 18% over the five years to Nov 9 while the S&P 500 rose 72%; up 13% since Oct 30.
2 reasons, from its filings, with the timeline, for Pro members.
| The chart | Above every average |
| Its score | Up:Up to Above Average for the first time since Feb 2026 |
| Latest filing | 10-Q, Nov 5 |
Tue Nov 17: Ex-dividend, $0.69 a shareAt the open. Pays Dec 17.
After its last 4 reports it closed -0.3% on average, higher 2 of 4 times.
Above Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. STE scores 14 today, against a median of 5 over its last 20 recorded sessions.
STE is #14 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 14 |
Net income over four quarters: STE $827M, EW $1.02B.
Expected to report Wed Feb 3, after the close (in 85 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.6B, 9% more than a year ago; a profit of $2.19 a share, from $1.94.
“The increase in operating income was primarily due to improved volume and price which were partially offset by inflation, lower productivity and investments.”
| Line | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Product | $817M | $737M | $745M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 5)
| Measure | Figure |
|---|---|
| Adjusted earnings per diluted share | $11.35 to $11.55 |
Sales grew 14% a year over 5 years, fiscal 2021 to 2026.
Pays $2.76 a share a year.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | +1.8% | +2.5% | not yet |
| Aug 5, 2026 | -7.8% | -0.4% | +1.7% |
| May 11, 2026 | +2.0% | +4.5% | +5.5% |
Sales grew every year from 2019 to 2026, to $5.9B. It made a profit in each of the eight years.
RSI 75.4, MACD above signal, above both averages. Not scored.
Its dividends come to 29% of its free cash flow.
| Dividend | $2.76 a share a year |
| Paid out | About $270M a year |
| Free cash flow | $937M |
| Record | Raised every year since 2017 |
2 insiders sold $1.3M across 2 filings in the last 6 months. No open-market buys on record. The newest:
20 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: STE is 0.1% of VIG, under 0.1% of DGRO, and under 0.1% of VOO, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Jul 31, 2026.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
“The markets in which we operate are highly competitive and generally highly regulated.”
STE scores 14 today, which Breakaway calls Above Average. It is #14 of 84 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 13% from Oct 30 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
STE scores 14 today, which Breakaway calls Above Average (11 to 14). That is #14 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind STE's 14.
2 insiders sold $1.3M across 2 filings in the last 6 months. No open-market buys on record. The newest is Mohsen Sohi, Director, who sold $957K on Aug 12. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.